中国医药导报
中國醫藥導報
중국의약도보
CHINA MEDICAL HERALD
2015年
12期
45-49
,共5页
肿瘤%S100P%研究
腫瘤%S100P%研究
종류%S100P%연구
Tumor%S100P%Research
近年来S100家族成员之一S100P在人类多种恶性肿瘤中的异常表达受到日益关注,其可能参与肿瘤细胞异常增殖、癌变、促进肿瘤浸润转移,与肿瘤分期及预后,乃至化疗药物耐药有关。本文就近几年关于S100P与恶性肿瘤关系的研究进展做一综述。
近年來S100傢族成員之一S100P在人類多種噁性腫瘤中的異常錶達受到日益關註,其可能參與腫瘤細胞異常增殖、癌變、促進腫瘤浸潤轉移,與腫瘤分期及預後,迺至化療藥物耐藥有關。本文就近幾年關于S100P與噁性腫瘤關繫的研究進展做一綜述。
근년래S100가족성원지일S100P재인류다충악성종류중적이상표체수도일익관주,기가능삼여종류세포이상증식、암변、촉진종류침윤전이,여종류분기급예후,내지화료약물내약유관。본문취근궤년관우S100P여악성종류관계적연구진전주일종술。
In recent years, the abnormal expression of S100P---a member of the S100 family in many human malig-nant tumors received increasing attention. It may be involved in the abnormal proliferation of tumor cells, canceration, promoting tumor invasion and metastasis. It is associated with tumor staging and prognosis, as well as chemotherapy re-sistance. In this paper, the research progress on relationship between S100P and malignant tumors are reviewed in the nearest few years.